title: Comparative study of hormonal dynamics in pregnant and nonpregnant cycles during pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile women.
abstract: OBJECTIVE
  To assess the clinical relevance of daily hormonal changes for achieving a successful pregnancy in anovulatory infertile women.
  
  
  METHODS
  A comparative study of hormonal dynamics in pregnant and nonpregnant cycles during the pulsatile subcutaneous administration of hMG. Subjects received subcutaneous injection of either 9.375 IU or 14.0625 IU of hMG diluted in 50-microL physiological saline (total daily dose, 150 or 225 IU) at 90-minute intervals by means of a portable peristaltic pump.
  
  
  METHODS
  Kyorin University Hospital and Ichikawa General Hospital.
  
  
  METHODS
  We analyzed 18 pregnant and 42 nonpregnant cycles in 17 patients with secondary hypothalamic/pituitary amenorrhea who conceived after receiving pulsatile hMG treatment. Another 14 women with normal spontaneous ovulation, including 14 pregnant and 15 nonpregnant cycles, served as controls.
  
  
  METHODS
  Serum concentrations of LH, FSH, E2, and P were measured, and the P:E2 ratio was determined.
  
  
  RESULTS
  Serum concentrations of LH and FSH did not differ significantly between the pregnant and nonpregnant cycles. Serum levels of P and E2 were significantly higher during the hMG treatments than those of the spontaneous ovulatory cycles throughout the follicular and luteal phases. Up to the midluteal phase, the P and E2 values in the nonpregnant cycles during the hMG treatments did not differ significantly from those in the pregnant cycles. The P:E2 ratios were comparable between the pulsatile stimulatory cycles and the normal spontaneous ovulatory cycles. However, the P:E2 ratio in the early and midluteal phases was significantly greater in the pregnant cycles than in the nonpregnant cycles.
  
  
  CONCLUSIONS
  The P:E2 ratio in the early and midluteal phases is a more important indicator of hormonal function for implantation than the absolute levels of either P or E2.
authors.affiliation: Department of Obstetrics and Gynecology, Kyorin University School of Medicine, Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Nakamura
authors.forename: Y
authors.initials: Y
authors.lastname: Yoshimura
authors.forename: T
authors.initials: T
authors.lastname: Oda
authors.forename: S
authors.initials: S
authors.lastname: Shiokawa
authors.forename: A
authors.initials: A
authors.lastname: Yoshinaga
authors.forename: M
authors.initials: M
authors.lastname: Akiba
mesh_terms: D000328:Adult; D000858:Anovulation / Q000097:blood / Q000188:drug therapy*; D005260:Female; D012739:Gonadal Steroid Hormones / Q000097:blood*; D006801:Humans; D007247:Infertility, Female / Q000097:blood / Q000188:drug therapy*; D007279:Injections, Subcutaneous; D008596:Menotropins / Q000008:administration & dosage* / Q000627:therapeutic use; D011247:Pregnancy / Q000097:blood*; D011673:Pulsatile Flow
chemical_list: D012739:Gonadal Steroid Hormones; D008596:Menotropins